The in vivo relevance of the NLRP3 inflammasome is well documented by its role in hereditary autoinflammatory syndromes (Masters et al, 2009) and by its role in the progression of metabolic diseases that are accompanied with inflammation such as atherosclerosis, diabetes and gout (Wen et al, 2012). Here, NLRP3 is linked to gout.